Author: editor_escrh

Dear ESC Member, Some countries needed to vote recently to appoint their representatives in the Board. We are pleased to welcome several new members (*) and two new countries who were not represented in the board in the past: Georgia and Malta. Here is the composition of the...

26th September is #WorldContraceptionDay. The aim of the day is not only to create awareness but also to spread facts and scientific evidence #WCD2020 Watch our webinar recording on Breast cancer risk associated with hormonal contraception and menopause hormone treatment https://escrh.eu/education/webinars Our ESC training improvement programme is updated: IUD...

Johannes Bitzer (Editor-in-Chief) chose the following paper as highlight from the latest issue of the European Journal of Contraception and Reproductive Health Care: Qualitative findings about stigma as a barrier to contraception use: the case of Emergency Hormonal Contraception in Britain and implications for future contraceptive...

Sessions on intrauterine contraception have been updated in the Training improvement Programme and are online now on the ESC homepage: https://escrh.eu/education/training-improvement-programme/ttt-tool-sessions-eng/ https://escrh.eu/education/training-improvement-programme/ In the session Intrauterine devices overview: copper-IUDs and LNG20-IUS (PDF / PDF With notes) published results of new research were added, particularly those related to the...

ESC Webinar: Breast cancer risk associated with hormonal contraception and menopause hormone treatment 16 September 2020 4 PM Central European Time Duration: 1 hour 30 minutes Hormonal contraception and breast cancer Gabriele Merki-Feld, MD PhD, Switzerland Breast cancer and menopause hormone therapy Anne Gompel, MD PhD, France   Registration...

ESC Webinar: Breast cancer risk associated with hormonal contraception and menopause hormone treatment 16 September 2020 4 PM Central EuropeanTime Duration: 1 hour 30 minutes Hormonal contraception and breast cancer Gabriele Merki-Feld, MD PhD, Switzerland Breast cancer and menopause hormone therapy Anne Gompel, MD PhD, France  ...

Progestin-only contraceptives (POCs) have become a popular alternative to combined hormonal contraceptives (CHC) as they are not associated with an increase in the risk of venous thrombosis or arterial events such as myocardial infarction or stroke. Oral POCs are very low dose and have minimal...

Johannes Bitzer (Editor-in-Chief) chose the following paper as highlight from the latest issue of the European Journal of Contraception and Reproductive Health Care: Living with the new coronavirus: How can a society cope with uncertainty Johannes Bitzer DOI: 10.1080/13625187.2020.1772968 This article is open access. Check also our ESC COVID-19 information...

Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy Salvatore Caruso, Stefano Cianci, Salvatore Giovanni Vitale, Valentina Fava, Silvia Cutello & Antonio Cianci Bleeding patterns for the Liletta® levonorgestrel 52 mg intrauterine system Courtney A. Schreiber, Stephanie...